Call SKYRIZI

The IL-23 inhibitor from AbbVie indicated for the treatment of adults with active psoriatic arthritis (PsA) and for moderate to severe plaque psoriasis (Ps) in adults who are candidates for systemic therapy or phototherapy.1

Nothing less than the opportunity to reach their treatment goals

For your patients, that’s everything.

FOR ADULTS WITH ACTIVE PSORIATIC ARTHRITIS1

VISIT THE U.S. SITE TO LEARN ABOUT THE EFFICACY AND SAFETY OF SKYRIZI IN ACTIVE PSORIATIC ARTHRITIS

AbbVie Contigo offers patients the resources and support they need
to start and stay on track with their SKYRIZI treatment plan as prescribed.

Enroll Your Patients Today

CARE SPECIALISTS*

Empower patients

Our Care Specialists are the heart behind the CONTIGO EXPERIENCE

Care Specialists provide 1:1 support for every patient. They help ensure patients have the correct resources and support they need, when they need them. They can:

  • Help patients understand the importance of following their treatment plan.
  • Offers personalized education and assistance to help patients incorporate treatment into their routine.
  • Help patients understand their insurance coverage.
  • Support patients in finding potential ways to save on their prescribed treatment and can connect them with additional access resources.
  • Provide supplemental injection training for patients ready to inject at home, delivered in person or during virtual interactions.

ACCESS SUPPORT

Insurance support when needed

  • Dealing with prescription drug coverage can be difficult.
  • Every patient’s situation is different, and prescription drug plans vary widely. No matter the patient’s financial or job status, there may be ways to lower the amount your patients pay for SKYRIZI.
  • We will help with finding potential ways to save on the cost of your prescription, understanding the insurance coverage, requirements and other financial support options available upon eligibility.
  • We will support patients navigating the insurance landscape for Commercial, Medicare and Medicaid health plans in Puerto Rico.

ACCESS & SAVINGS

Help with access & treatment affordability

AbbVie Contigo can help your commercial patients save:

  • With the Ahorros Contigo Savings Card, your eligible commercially insured patients may pay as little as $5 per prescription.†

Patients can also register over the phone by
calling 1-855-CONTIGO (1-855-266-8446)

*Care Specialists are provided by AbbVie and do not provide medical advice or work under the direction of the prescribing health care professional (HCP). They are trained to direct patients to speak with their HCP about any treatment-related questions, including further referrals.

†Terms and Conditions apply. This benefit covers SKYRIZI® (risankizumab-rzaa). Eligibility: Available to patients with commercial prescription insurance coverage for SKYRIZI who meet eligibility criteria. Co-pay assistance program is not available to patients receiving prescription reimbursement under any federal, state, or government-funded insurance programs (for example, Medicare [including Part D], Medicare Advantage, Medigap, Medicaid, TRICARE, Department of Defense, or Veterans Affairs programs) or where prohibited by law or by the patient’s health insurance provider. If at any time a patient begins receiving prescription drug coverage under any such federal, state, or government-funded healthcare program, patient will no longer be able to use the Ahorros Contigo Savings Card for SKYRIZI and patient must call AbbVie Contigo at 1.855.CONTIGO to stop participation. Patients moving or residing outside Puerto Rico may not be eligible. Patients may not seek reimbursement for value received from the AbbVie Contigo program from any third-party payers. Offer subject to change or discontinuance without notice. Restrictions, including monthly maximums, may apply. This assistance offer is not health insurance. To learn about AbbVie’s privacy practices and your privacy choices, visit www.abbvie.com/privacy.html.